SPRINT Trial: NF1 With PNs
0 意见
• 07/02/23
0
0
嵌入
A review of the phase 2 SPRINT study using selumetinib for the treatment of neurofibromatosis type 1 with plexiform neurofibromas.
Website: https://www.onclive.com
Twitter: https://twitter.com/OncLive
Facebook: https://www.facebook.com/OncLive/
LinkedIn: https://www.linkedin.com/company/onclive
显示更多
脸书评论
SORT BY-
热门评论
-
最新评论